₹872.2▲0.75%
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.46 % |
3 Month Return | + 17.81 % |
1 Year Return | + 15.89 % |
Market Stats | |
Previous Close | ₹865.75 |
Open | ₹862.60 |
Volume | 3,294.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹382.08Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹382.08 Cr |
P/B Ratio | 2.1 |
EPS | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
Jenburkt Pharmaceuticals Ltd | NA | ₹382.08 Cr | 11.7% | 0.51 | NA | NA |
Decipher Labs Ltd | NA | ₹17.18 Cr | -6.84% | 0.50 | -₹3 Cr | ₹45 Cr |
Syschem (India) Ltd | NA | ₹164.28 Cr | 90.19% | 0.58 | NA | NA |
Kopran Ltd | NA | ₹1,131.02 Cr | 120.9% | 0.54 | ₹27 Cr | ₹550 Cr |
Beryl Drugs Ltd | NA | ₹14.76 Cr | 80.9% | 0.69 | NA | NA |
Organisation | Jenburkt Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, Jenburkt Pharma stock has moved up by 17.8%
Retail Holding Up
Retail Investor have increased holdings from 52.77% to 53.29% in Jun 2024 quarter
Against Peers
In the last 1 year, Zydus Lifesciences Ltd has given 87.2% return, outperforming this stock by 71.3%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 127.7% return, outperforming this stock by 54.1%
Promoter Holding Down
Promoters have decreased holdings from 47.23% to 46.71% in Jun 2024 quarter
2024 | Y/Y Change | |
---|---|---|
Total Assets | ₹166.69Cr | ↑16.61% |
Total Liabilities | ₹21.75Cr | ↑5.79% |
2024 | Y/Y Change | |
---|---|---|
Operating Cash Flow | ₹8.12Cr | ↓52.38% |
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 46.71% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 53.29% | 0.99 | |
Others | 0% | 0.00 |
Jenburkt Pharmaceuticals Ltd’s net profit jumped 24.09% since last year same period to ₹7.88Cr in the Q4 2023-2024. On a quarterly growth basis, Jenburkt Pharmaceuticals Ltd has generated 45.93% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Jenburkt Pharmaceuticals Ltd has declared dividend of ₹15.30 - translating a dividend yield of 1.75%.
Read More about DividendsBearish
Neutral
Bullish
Jenburkt Pharmaceuticals Ltd is currently in a Bullish trading position according to technical analysis indicators.
Jenburkt Pharmaceuticals Ltd (524731) share price today is ₹872.2
Jenburkt Pharmaceuticals Ltd is not listed on NSE
Jenburkt Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Jenburkt Pharmaceuticals Ltd(524731) is 3,294.00.
Today’s market capitalisation of Jenburkt Pharmaceuticals Ltd(524731) is ₹382.08Cr.
Jenburkt Pharmaceuticals Ltd(524731 | Price |
---|---|
52 Week High | ₹925 |
52 Week Low | ₹586.9 |
Jenburkt Pharmaceuticals Ltd(524731) share price is ₹872.2. It is down -5.71% from its 52 Week High price of ₹925
Jenburkt Pharmaceuticals Ltd(524731) share price is ₹872.2. It is up 48.61% from its 52 Week Low price of ₹586.9
Jenburkt Pharmaceuticals Ltd(524731 | Returns |
---|---|
1 Day Returns | 6.45% |
1 Month Returns | -1.46% |
3 Month Returns | 17.81% |
1 Year Returns | 15.89% |